Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 46 Schemes (35.71%)
Foreign Institutions
Held by 76 Foreign Institutions (9.85%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2026)
Net Profit:
-41 Million
Pharmaceuticals & Biotechnology
USD 263 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.03
-999,999.00%
0.93






